UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

~~PURSUANT~~UNDER ~~TO RULE 13a-16 OR 15d-16~~

~~UNDER~~ THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~September~~October 2015

Commission File Number: 000-55169

Medifocus Inc.

(Translation of registrant’s name into English)

10240 Old Columbia Road, Suite G

Columbia, Maryland 21046

(410) 290 - 5734

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x þ Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No xþ

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): ________.

DOCUMENTS FILED AS PART OF THIS FORM 6-K

The following document, filed as exhibits to this Form 6-K, are incorporated by reference as part of this Form 6-K:

Exhibit		Description of Exhibit
99.1		Medifocus MD and A for the three Months Ended June 30, 2015
99.1 99.2 99.3 99.4 99.5		Medifocus Inc. Units Offering Medifocus Virtual Investor Conferences Medifocus 100,000 Prolieve Treatment Milestone Medifocus Duke License Agreement Medifocus – 5th Annual BIT Conference
		Medifocus Financial Statements for the Three Months Ended June 30, 2015
		CEO cert 0911
		CFO cert 0911

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MEDIFOCUS INC. /s/ Augustine Cheung Augustine Cheung, Ph.D. Chief Executive Officer


	MEDIFOCUS INC.

		/s/ Augustine Cheung
		Augustine Cheung, Ph.D.
		Chief Executive Officer
Date: October 21, 2015

Date: September 4, 2015

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Medifocus MD and A for the three Months Ended June 30, 2015
99.1 99.2 99.3 99.4 99.5		Medifocus Inc. Units Offering Medifocus Virtual Investor Conferences Medifocus 100,000 Prolieve Treatment Milestone Medifocus Duke License Agreement Medifocus – 5th Annual BIT Conference
		Medifocus Financial Statements for the Three Months Ended June 30, 2015
		CEO cert 0911
		CFO cert 0911

Filing Compare · Medifocus Inc.